Brent Sheather is an Authorised Financial Adviser at Private Asset Management

ACC v NZ Super Fund on fees, horizons and returns


Opinion: Comparing the two largest government-owned funds and what they are telling investors.

FMA's Paul Gregory hopes the tool can help test fund's rhetoric with the reality.

FMA's new KiwiSaver Tracker gets mixed reception

Tue 21 Nov 7

The new tool visualises fund data to help investors see how they are performing in relation to fees.

Morningstar equity research director Adam Fleck makes his pick.

Auckland Airport or Sydney Airport? Analyst weighs up the two

Wed 8 Nov

Which airport makes a better investment?

Software Industry Group chairman Ronald Weissman says if a management team or a CEO is dishonest, then that's an instant deal killer

The other side of the pitch: what angel investors want to hear

Mon 6 Nov 8

Every new idea probably has a kernel of opportunity, so how can investors separate the wheat from the chaff? By looking at the character of the founder.

Aroa Biosurgery chief executive Brian Ward says a public listing is possible once it has "certainty of revenue" (photo: Jerry Yelich-O'Connor)

Kiwi biotech Aroa Biosurgery gets 'shot in the arm' from investment in US partner

Wed 1 Nov

Tela Bio has up to $US25 million to scale sales and clinical trials of Kiwi-developed regenerative tissue technology.

Bethunes Investments chairman Chris Swasbrook says new BIL will be re-listed on NZX at some time in the future as an investment vehicle

Bethunes hopes it's second time lucky with TIL Logistics backdoor listing

Fri 27 Oct 6

Transport Logistics will gain the listing but Bethunes will live on.


Subscribe to Investment